
Lurie Children’s Becomes First Treatment Center for Zevaskyn Gene Therapy in Patients with RDEB
Abeona Therapeutics and Ann & Robert H. Lurie Children’s Hospital of Chicago recently announced that Lurie Children's is now the first qualified treatment center in the United States to offer Zevaskyn (prademagene zamikeracel; pz-cel), a newly …